We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTR
1276
DELISTED
Frontier Communications Corp.
FTR
$10.7M ﹤0.01%
143,787
-2,267,911
-94% -$178M
URI icon
1277
United Rentals
URI
$69.7B
$10.5M ﹤0.01%
156,670
-6,600
-4% -$431K
TMUSP
1278
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
$10.4M ﹤0.01%
142,794
-815,056
-85% -$57.3M
CLNY
1279
DELISTED
Colony Capital, Inc.
CLNY
$10.4M ﹤0.01%
675,910
+2,620
+0.4% +$45.5K
WSM icon
1280
Williams-Sonoma
WSM
$28.5B
$10.3M ﹤0.01%
396,146
+9,814
+3% +$269K
MNTA
1281
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$10.3M ﹤0.01%
951,864
-56,700
-6% -$585K
AIZ icon
1282
Assurant
AIZ
$13.9B
$10.3M ﹤0.01%
118,775
-4,950
-4% -$416K
OB
1283
DELISTED
Onebeacon Insurance Group Ltd
OB
$10.2M ﹤0.01%
736,142
+472,873
+180% +$6.1M
CVLT icon
1284
Commault Systems
CVLT
$6.26B
$10.1M ﹤0.01%
234,920
+109,400
+87% +$4.83M
SNI
1285
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$10.1M ﹤0.01%
162,740
-1,350
-0.8% -$86.2K
AOS icon
1286
A.O. Smith
AOS
$8.49B
$10.1M ﹤0.01%
228,494
-3,178
-1% -$128K
HRB icon
1287
H&R Block
HRB
$6.76B
$10.1M ﹤0.01%
437,408
-6,010
-1% -$134K
FDC
1288
DELISTED
First Data Corporation
FDC
$9.97M ﹤0.01%
900,810
-1,019,822
-53% -$12.2M
WFBI
1289
DELISTED
WashingtonFirst Bankshares Inc
WFBI
$9.91M ﹤0.01%
481,499
+161,333
+50% +$3.35M
CRVL icon
1290
CorVel
CRVL
$3.25B
$9.9M ﹤0.01%
687,558
+8,700
+1% +$131K
CEB
1291
DELISTED
CEB Inc.
CEB
$9.79M ﹤0.01%
158,690
NVRI icon
1292
Enviri
NVRI
$564M
$9.77M ﹤0.01%
1,471,720
-1,783,290
-55% -$11.6M
VASC
1293
DELISTED
Vascular Solutions Inc
VASC
$9.75M ﹤0.01%
+234,020
New +$8.71M
ZION icon
1294
Zions Bancorporation
ZION
$10.5B
$9.68M ﹤0.01%
385,273
+48,500
+14% +$1.29M
CPHD
1295
DELISTED
Cepheid Inc
CPHD
$9.68M ﹤0.01%
314,652
+12,300
+4% +$372K
LECO icon
1296
Lincoln Electric
LECO
$15.5B
$9.64M ﹤0.01%
163,140
-12,186
-7% -$734K
TGNA
1297
DELISTED
TEGNA Inc
TGNA
$9.61M ﹤0.01%
647,864
-63
-0% -$921
PPS
1298
DELISTED
Post Properties
PPS
$9.55M ﹤0.01%
156,361
-7,681
-5% -$454K
AXE
1299
DELISTED
Anixter International Inc
AXE
$9.51M ﹤0.01%
178,470
-3,600
-2% -$206K
SFLY
1300
DELISTED
Shutterfly, Inc.
SFLY
$9.43M ﹤0.01%
202,400
+11,400
+6% +$535K

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.